(Q42949441)

11 November 2017

title

Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type1 diabetes (English)

1 reference

11 November 2017

Inhibition of the renal renin‐angiotensin system and renoprotection by pitavastatin in type 1 diabetes (English)

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

15 June 2024

author name string

Hiroe Toba

1

1 reference

11 November 2017

Takuya Mitani

2

1 reference

11 November 2017

Tamotsu Takahashi

3

1 reference

11 November 2017

Nobuyoshi Imai

4

1 reference

11 November 2017

Ryoko Serizawa

5

1 reference

11 November 2017

Jiahong Wang

6

1 reference

11 November 2017

Miyuki Kobara

7

1 reference

11 November 2017

Tetsuo Nakata

8

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20678154

15 June 2024

publication date

1 November 2010

1 reference

full work available at URL

11 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1681.2010.05436.x

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1681.2010.05436.x

15 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Clinical and Experimental Pharmacology and Physiology

15 June 2024

published in

1 reference

11 November 2017

volume

37

1 reference

11 November 2017

issue

11

1 reference

11 November 2017

page(s)

1064-1070

1 reference

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05436.X

Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05436.X

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2010.05436.X

Inhalation of levomepromazine in severe acute asthma

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

15 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

15 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

15 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

15 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

15 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis

15 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Postischemic acute renal failure is reduced by short-term statin treatment in a rat model

15 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy

15 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model

15 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress

15 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

15 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Rho GTPases, statins, and nitric oxide

15 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

15 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

15 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension

15 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men

15 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production

15 June 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency

15 June 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes

15 June 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Mean glomerular volume and rate of development of diabetic nephropathy

15 June 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

The renal tubulointerstitium in diabetes mellitus

15 June 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats

15 June 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

15 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta

15 June 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

15 June 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes

15 June 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

15 June 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Acute onset and worsening of diabetes concurrent with administration of statins

15 June 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats

15 June 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

15 June 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

15 June 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor

15 June 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats

15 June 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Nitric oxide in cardiovascular disorders

15 June 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Nitric oxide: physiology, pathophysiology, and pharmacology

15 June 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure

15 June 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor

15 June 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Regulation of the mevalonate pathway

15 June 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

15 June 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Rho GTPases and signaling networks

15 June 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Real time quantitative PCR

15 June 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes

15 June 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

Control of cardiac gene expression by mechanical stress

15 June 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy

15 June 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.2010.05436.X

15 June 2024

Identifiers

1 reference

11 November 2017

1 reference